IRBMED Fees
Memorandum
TO: Medical School Department Chairs and Administrators
FROM: Steve A. Goldstein, Ph.D., Associate Dean for Research and Graduate Studies
William R. Elger, Executive Director for Administration and Chief Financial Officer
DATE: January 21, 2003
RE: IRB fee for industrial sponsors
The Medical School announces an increase in the IRBMED fee charged to industry sponsors.
For the first time since 1997, when the fee was introduced, the Medical School will increase the charge to industrial sponsors for review of protocols involving human research participants by the Medical School's Institutional Review Boards. The fee will increase from $1,000 to $1,800.
Sponsored projects being routed to the Medical School Grants Office will be expected to carry the new rate as of February 17, 2003. Previously reviewed proposals, or those undergoing current review, may be grandfathered into this system. The Medical School Grants Office will make the determinations for any exceptions to the new fee during this transition.
A review of peer institutions indicates this increased fee is consistent within the practices of the group. Industrial sponsors of research involving human subjects are accustomed to paying fees for IRB review as a direct cost line item in the study budget.
We will further communicate this information to the research community via the Biomedical Research News, E-News, and some targeted e-mail groups.
If you have any questions about implementation, please contact the Medical School Grants Office at 763-4272.
This page is maintained by UMHS Public Relations & Marketing Communications. Contact UMMS
(c) copyright 2008 Regents
of the University of Michigan
